Literature DB >> 21291773

Plasma lipid profile and lipid peroxidation in beta-thalassemic children.

Mona Ramadan Nasr1, Awatef M Abdelmaksoud, Kholooud Salah Eldin Abd El-Aal, Naglaa Abdul-Zaher Mabrouk, Wafaa Muhamed Ismael.   

Abstract

BACKGROUND: Beta-thalassaemic patients who usually have a combination of; chronic hemolytic anemia, iron storage disease, myocarditis, and premature death especially due to heart failure may also have increased oxidation of lipids and abnormal lipoprotein concentrations.
OBJECTIVE: To determine plasma lipids, triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and lipid peroxidation product malondialdehyde (MDA) in children with β-thalassemia and unaffected control children. Relationships with age, gender, hemoglobin, serum iron, and serum ferritin were examined. Children with β-thalassemia (28 males and 15 females, aged 4 to 18 years) and 31 age- and gender-matched healthy controls were studied.
RESULTS: In children with β-thalassemia, there was an increase in TG, MDA, and the MDA/LDL-C ratio (P = .000) and a decrease in TC, LDL-C, HDL-C, and the LDL-C/ TG ratio (P < .001) compared to unaffected controls. The LDL-C/HDL-C ratio was not different. The MDA/LDL-C ratio was correlated negatively with blood hemoglobin and TC (P < .05 for each), whereas the LDL-C/HDL-C ratio was correlated with age, weight, body mass index, and TC (P < .05, < .05, < .05, and < .01 respectively).
CONCLUSION: Despite the derangement in plasma lipid profile in children with β-thalassemia accompanied by excess lipid peroxidation, the lipoprotein concentrations do not suggest increased risk. The MDA/LDL-C ratio may prove to be a valuable marker for lipid peroxidation.

Entities:  

Year:  2008        PMID: 21291773     DOI: 10.1016/j.jacl.2008.10.008

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  4 in total

1.  Al-hijamah (the triple S treatment of prophetic medicine) exerts cardioprotective, tissue-protective and immune potentiating effects in thalassemic children: a pilot clinical trial.

Authors:  Mohamed El-Shanshory; Nahed Mohammed Hablas; Yasmin Shebel; Osama Alhadramy; Rehab El-Tahlawi; Moutasem Salih Aboonq; Tamer M Soliman; Abdelhady Ragab Abdel-Gawad; Sayed Mostafa El Sayed; Hesham I Abdallah; Hany Salah Mahmoud; Hassan El-Allaf; Samer El-Sawy; Reda S Yousef; Mostafa Abu-El Naga; Reham A Mariah; Manal Mohamed Helmy Nabo; Mohamed Abdel-Haleem; Ahmed Alamir Mahmoud; Mohammad Ahmad Hassan; Areej Hesham Al Arabi; Abdullah Ahmed Alnakhli; Salah Mohamed El Sayed
Journal:  Am J Blood Res       Date:  2020-12-15

2.  Iron loading impairs lipoprotein lipase activity and promotes hypertriglyceridemia.

Authors:  Jonghan Kim; Xuming Jia; Peter D Buckett; Sihao Liu; Chih-Hao Lee; Marianne Wessling-Resnick
Journal:  FASEB J       Date:  2012-12-14       Impact factor: 5.191

3.  Serum Lipids in Turkish Patients with β-Thalassemia Major and β-Thalassemia Minor.

Authors:  Yasemin Işık Balcı; Şule Ünal; Fatma Gümrük
Journal:  Turk J Haematol       Date:  2015-04-06       Impact factor: 1.831

4.  Plasma proteome profiling combined with clinical and genetic features reveals the pathophysiological characteristics of β-thalassemia.

Authors:  Na Li; Peng An; Jifeng Wang; Tingting Zhang; Xiaoqing Qing; Bowen Wu; Lang Sun; Xiang Ding; Lili Niu; Zhensheng Xie; Mengmeng Zhang; Xiaojing Guo; Xiulan Chen; Tanxi Cai; Jianming Luo; Fudi Wang; Fuquan Yang
Journal:  iScience       Date:  2022-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.